SCHEMBL1750360

SCHEMBL1750360

CC(C)(C)C(Cc1cccc(-c2ccc(/C=C3/SC(=O)NC3=O)s2)c1)NC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PRF1 P14222 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PIK3CG P48736 2/20 0.42
PIK3CA P42336 1/20 0.42
PTPN1 P18031 3/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
HPGD P15428 7/20 0.39
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
PPARA Q07869 1/20 0.38
NR1H4 Q96RI1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1750363 1.00 PRF1 (0.47) PRF1TDP1PIK3CGPIK3CAPTPN1
SCHEMBL1750860 0.82 HPGDS (0.42) PRF1HPGD
SCHEMBL1751361 0.81 PRF1 (0.50) PRF1TDP1PIK3CGPIK3CAPTPN1
SCHEMBL1082139 0.80 PRF1 (0.57) PRF1TDP1PIK3CGPIK3CAPTPN1
SCHEMBL1082137 0.80 PRF1 (0.57) PRF1TDP1PIK3CGPIK3CAPTPN1
SCHEMBL12931807 0.80 PRF1 (0.57) PRF1TDP1PIK3CGPIK3CAPTPN1
SCHEMBL1751358 0.79 TDP1 (0.50) PRF1TDP1PIK3CGPIK3CAPTPN1
SCHEMBL1751360 0.79 TDP1 (0.50) PRF1TDP1PIK3CGPIK3CAPTPN1
SCHEMBL1750365 0.78 PRF1 (0.47) PRF1TDP1PIK3CGPIK3CAPTPN1
SCHEMBL1064124 0.76 TDP1 (0.75) PRF1TDP1PIK3CGPIK3CAMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022079-B2 Methods of modulating PPAR gamma-type receptors GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-09-20 US disclosed
EP-1638964-B1 NOVEL COMPOUNDS THAT MODULATE PPAR-GAMMA TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RES & DEV (FR) 2011-07-27 EP disclosed